ATE427116T1 - Behandlung von bakteriellen infektionen - Google Patents
Behandlung von bakteriellen infektionenInfo
- Publication number
- ATE427116T1 ATE427116T1 AT05717847T AT05717847T ATE427116T1 AT E427116 T1 ATE427116 T1 AT E427116T1 AT 05717847 T AT05717847 T AT 05717847T AT 05717847 T AT05717847 T AT 05717847T AT E427116 T1 ATE427116 T1 AT E427116T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- treatment
- bacterial infections
- objects
- nucleic acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0404374.1A GB0404374D0 (en) | 2004-02-27 | 2004-02-27 | Treatment of bacterial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE427116T1 true ATE427116T1 (de) | 2009-04-15 |
Family
ID=32050981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05717847T ATE427116T1 (de) | 2004-02-27 | 2005-02-28 | Behandlung von bakteriellen infektionen |
Country Status (11)
Country | Link |
---|---|
US (1) | US8524861B2 (de) |
EP (1) | EP1718325B1 (de) |
JP (2) | JP5270150B2 (de) |
CN (1) | CN1925866B (de) |
AT (1) | ATE427116T1 (de) |
AU (1) | AU2005216703B2 (de) |
CA (1) | CA2554486C (de) |
DE (1) | DE602005013648D1 (de) |
ES (1) | ES2324481T3 (de) |
GB (1) | GB0404374D0 (de) |
WO (1) | WO2005082399A2 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9216106B2 (en) | 2003-04-09 | 2015-12-22 | Directcontact Llc | Device and method for the delivery of drugs for the treatment of posterior segment disease |
GB0329958D0 (en) | 2003-12-24 | 2004-01-28 | Univ Manchester | Treatment of viral infections |
GB0404374D0 (en) | 2004-02-27 | 2004-03-31 | Univ Manchester | Treatment of bacterial infections |
EP3031466B1 (de) * | 2004-07-06 | 2018-11-28 | 3D Matrix, Inc. | Gereinigte zusammensetzungen amphiphiler peptide und verwendungen davon |
GB0513096D0 (en) * | 2005-06-28 | 2005-08-03 | Strathclyde | Treatment of microbial infections |
WO2008080082A2 (en) | 2006-12-21 | 2008-07-03 | Cognosci, Inc. | Methods for modulating set and uses thereof |
GB0818074D0 (en) * | 2008-10-02 | 2008-11-05 | Lytix Biopharma As | Treatment of biofilms |
CN105435211A (zh) | 2008-10-06 | 2016-03-30 | 三维肽胶株式会社 | 组织闭塞剂 |
FR2937322B1 (fr) * | 2008-10-22 | 2013-02-22 | Vect Horus | Derives peptidiques et leur utilisation comme vecteurs de molecules sous forme de conjugues |
US20110046747A1 (en) * | 2009-02-19 | 2011-02-24 | Kelvin Wai Kwok Yeung | Antibacterial surface and method of fabrication |
JP2012180302A (ja) * | 2011-03-01 | 2012-09-20 | Tokai Univ | 抗グラム陰性菌剤 |
WO2013013187A1 (en) * | 2011-07-21 | 2013-01-24 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Apolipoprotein e polypeptides and their use |
US8979260B1 (en) * | 2011-10-18 | 2015-03-17 | Indicator Systems International, Inc. | Contact lenses with indicators |
WO2014008400A2 (en) | 2012-07-06 | 2014-01-09 | 3-D Matrix, Inc. | Fill-finish process for peptide solutions |
KR101553685B1 (ko) * | 2014-01-28 | 2015-09-17 | 주식회사 인터로조 | 항균성의 하이드로겔 콘택트렌즈 및 그 제조방법 |
GB201401877D0 (en) * | 2014-02-04 | 2014-03-19 | Univ Tromsoe | Peptides |
WO2015136370A2 (en) * | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Sterilization and filtration of peptide compositions |
US10245299B2 (en) | 2014-03-10 | 2019-04-02 | 3-D Matrix, Ltd. | Autoassembling peptides for the treatment of pulmonary bulla |
US10654893B2 (en) | 2014-03-10 | 2020-05-19 | 3-D Matrix, Ltd. | Self-assembling peptide compositions |
CN104974228B (zh) * | 2015-06-15 | 2017-10-17 | 四川合泰新光生物科技有限公司 | 一种小分子多肽zy4及其应用 |
WO2017120092A1 (en) | 2016-01-06 | 2017-07-13 | 3-D Matrix, Ltd. | Combination compositions |
CN117085140A (zh) | 2017-12-15 | 2023-11-21 | 立美基股份有限公司 | 表面活性剂肽纳米结构及在药物递送中的用途 |
CN112480230B (zh) * | 2020-11-30 | 2022-05-03 | 青岛农业大学 | 一种具有更好抗热功能的抗菌肽及其应用 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5294605A (en) | 1990-07-19 | 1994-03-15 | The Scripps Research Institute | Amphiphilic peptide compositions and analogues thereof |
US5344822A (en) | 1992-08-12 | 1994-09-06 | The Rogosin Institute | Methods useful in endotoxin prophylaxis and therapy |
FR2697022B1 (fr) * | 1992-10-19 | 1994-12-16 | Pasteur Institut | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. |
JP2000501386A (ja) * | 1995-11-14 | 2000-02-08 | ゾーマ コーポレイション | 角膜損傷に関連する病態を処置するための、殺菌性/透過性増強(bpi)タンパク質 |
GB9705831D0 (en) | 1997-03-20 | 1997-05-07 | Univ Leicester | Oxidised ldl |
KR100314721B1 (ko) | 1998-01-22 | 2001-11-23 | 김일웅 | 생물학적 활성이 있는 신규한 펩타이드 |
WO1999045950A2 (en) | 1998-03-11 | 1999-09-16 | Duke University | Methods of suppressing microglial activation |
US7205280B2 (en) | 1998-03-11 | 2007-04-17 | Cognosci, Inc. | Methods of suppressing microglial activation |
AU4315300A (en) * | 1999-04-30 | 2000-11-17 | Keio University | Method for inducing the cell death of nerve cell line, method for screening compound inhibiting or promoting the cell death of nerve cells, and cell death inhibitor and promoter for nerve cells |
US6664230B1 (en) | 2000-08-24 | 2003-12-16 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
GB0103424D0 (en) * | 2001-02-12 | 2001-03-28 | Chiron Spa | Gonococcus proteins |
US20040014955A1 (en) | 2001-12-17 | 2004-01-22 | Carlos Zamudio | Identification of essential genes of cryptococcus neoformans and methods of use |
CN1269837C (zh) * | 2002-09-02 | 2006-08-16 | 上海高科联合生物技术研发有限公司 | 一组合成抗菌肽 |
US20050208078A1 (en) * | 2003-11-20 | 2005-09-22 | Hoffman Stephen L | Methods for the prevention of malaria |
WO2005039534A1 (en) | 2003-10-01 | 2005-05-06 | Children's Hospital & Research Center At Oakland | Lipophilic drug delivery vehicle and methods of use thereof |
EP1682516A2 (de) * | 2003-11-13 | 2006-07-26 | Janssen Pharmaceutica N.V. | Immobilisierte n-substituierte tricyclische 3-aminopyrazole zur identifikation biomolekularer ziele |
GB0329254D0 (en) * | 2003-12-17 | 2004-01-21 | Univ Manchester | Treatment of viral infections |
GB0329958D0 (en) * | 2003-12-24 | 2004-01-28 | Univ Manchester | Treatment of viral infections |
GB0404374D0 (en) | 2004-02-27 | 2004-03-31 | Univ Manchester | Treatment of bacterial infections |
GB0513096D0 (en) * | 2005-06-28 | 2005-08-03 | Strathclyde | Treatment of microbial infections |
-
2004
- 2004-02-27 GB GBGB0404374.1A patent/GB0404374D0/en not_active Ceased
-
2005
- 2005-02-28 AT AT05717847T patent/ATE427116T1/de not_active IP Right Cessation
- 2005-02-28 WO PCT/GB2005/000769 patent/WO2005082399A2/en active Application Filing
- 2005-02-28 US US10/586,416 patent/US8524861B2/en active Active
- 2005-02-28 DE DE602005013648T patent/DE602005013648D1/de active Active
- 2005-02-28 AU AU2005216703A patent/AU2005216703B2/en not_active Ceased
- 2005-02-28 CA CA2554486A patent/CA2554486C/en active Active
- 2005-02-28 ES ES05717847T patent/ES2324481T3/es active Active
- 2005-02-28 EP EP05717847A patent/EP1718325B1/de not_active Not-in-force
- 2005-02-28 CN CN2005800062153A patent/CN1925866B/zh not_active Expired - Fee Related
- 2005-02-28 JP JP2007500301A patent/JP5270150B2/ja not_active Expired - Fee Related
-
2012
- 2012-10-29 JP JP2012237647A patent/JP2013051965A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1718325A2 (de) | 2006-11-08 |
CN1925866B (zh) | 2012-09-05 |
US8524861B2 (en) | 2013-09-03 |
US20090169598A1 (en) | 2009-07-02 |
ES2324481T3 (es) | 2009-08-07 |
AU2005216703A2 (en) | 2005-09-09 |
AU2005216703B2 (en) | 2011-06-23 |
CN1925866A (zh) | 2007-03-07 |
JP2007524420A (ja) | 2007-08-30 |
CA2554486A1 (en) | 2005-09-09 |
JP5270150B2 (ja) | 2013-08-21 |
WO2005082399A2 (en) | 2005-09-09 |
GB0404374D0 (en) | 2004-03-31 |
CA2554486C (en) | 2013-09-17 |
WO2005082399A3 (en) | 2005-12-22 |
DE602005013648D1 (de) | 2009-05-14 |
JP2013051965A (ja) | 2013-03-21 |
EP1718325B1 (de) | 2009-04-01 |
AU2005216703A1 (en) | 2005-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE427116T1 (de) | Behandlung von bakteriellen infektionen | |
CY1110177T1 (el) | Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης | |
ATE524195T1 (de) | Monoklonale antikörper gegen das clfa-protein und verfahren zur verwendung bei der behandlung bzw. pr vention von infektionen | |
NO20050210L (no) | Antibakterielle amid-makrocykluser | |
CY1111225T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c | |
EA200600280A1 (ru) | Композиции на основе производных липопептидных антибиотиков и способы их применения | |
DE60330161D1 (de) | Rifalazil zur behandlung von infektionen mit clostridium difficile | |
NO20083245L (no) | Sykliske antimikrobielle peptider | |
ATE452138T1 (de) | Antibakterielle peptide und analoga davon | |
ATE310089T1 (de) | Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen | |
ATE335499T1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
ATE486634T1 (de) | Caspase 3, 8, 9 oder 10 inhibitoren in kombination mit mek inhibitoren zur behandlung von influenza | |
MX2017016227A (es) | Peptidos anti-infecciosos de amplio espectro. | |
WO2004098536A3 (en) | Anti-viral activity of cathelicidin peptides | |
DE69914911D1 (de) | Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen | |
RS52448B (en) | ANTITUMOR PHARMACEUTICAL COMPOSITION CONTAINING SERALIZIN POLYPEPTIDE FRAGMENTS | |
DE602004025689D1 (de) | Antivirale mittel zur behandlung, kontrolle und prävention von infektionen durch coronaviren | |
BRPI0411168A (pt) | composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos | |
BRPI0410967A (pt) | compostos, composições e seus usos para o tratamento de infecções por vìrus da famìlia flaviviridae | |
HUP0401586A2 (hu) | Baktériumellenes szer | |
DE602004006287D1 (de) | Korrosionsschutzmittel zur oberflächlichen behandlung von gläsernem spülgut | |
ATE544453T1 (de) | Kombinationstherapien mit l-fmau zur behandlung von hepatitis-b-virus-infektionen | |
ATE441461T1 (de) | Mittel zur behandlung von infektionen | |
WO2006129090A3 (en) | Vaccines | |
DE602004012759D1 (de) | Behandlung von fibrosen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |